Estrogens and breast cancer

In this review, we summarize the epidemiologic evidence for the associations of oral contraceptives and postmenopausal hormones with risk of breast cancer. We also describe the biologic plausibility of these relationships. Overall, there appears to be little, if any, increase in risk with oral contr...

Full description

Bibliographic Details
Main Authors: HANKINSON SUSAN E, STAMPFER MEIR J
Format: Article
Language:English
Published: Instituto Nacional de Salud Pública 1997-01-01
Series:Salud Pública de México
Subjects:
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36341997000400014
_version_ 1818343284451311616
author HANKINSON SUSAN E
STAMPFER MEIR J
author_facet HANKINSON SUSAN E
STAMPFER MEIR J
author_sort HANKINSON SUSAN E
collection DOAJ
description In this review, we summarize the epidemiologic evidence for the associations of oral contraceptives and postmenopausal hormones with risk of breast cancer. We also describe the biologic plausibility of these relationships. Overall, there appears to be little, if any, increase in risk with oral contraceptive use in general, even among users for 10 or more years. However, compared to never users, current oral contraceptive users appear to have a modest elevation in risk that subsides within about 10 years after cessation of use. For postmenopausal hormones, the weight of the evidence suggests little or no increase in risk among users of short duration, or for use in the past. However, current longer term use is associated with an increased risk of breast cancer that increases with duration. This increase in risk is large enough, and well enough supported, to be considered along with the other risks and benefits of postmenopausal hormone therapy.
first_indexed 2024-12-13T16:28:08Z
format Article
id doaj.art-023f6bf677f945f1931e8a2975915197
institution Directory Open Access Journal
issn 0036-3634
language English
last_indexed 2024-12-13T16:28:08Z
publishDate 1997-01-01
publisher Instituto Nacional de Salud Pública
record_format Article
series Salud Pública de México
spelling doaj.art-023f6bf677f945f1931e8a29759151972022-12-21T23:38:34ZengInstituto Nacional de Salud PúblicaSalud Pública de México0036-36341997-01-01394370378Estrogens and breast cancerHANKINSON SUSAN ESTAMPFER MEIR JIn this review, we summarize the epidemiologic evidence for the associations of oral contraceptives and postmenopausal hormones with risk of breast cancer. We also describe the biologic plausibility of these relationships. Overall, there appears to be little, if any, increase in risk with oral contraceptive use in general, even among users for 10 or more years. However, compared to never users, current oral contraceptive users appear to have a modest elevation in risk that subsides within about 10 years after cessation of use. For postmenopausal hormones, the weight of the evidence suggests little or no increase in risk among users of short duration, or for use in the past. However, current longer term use is associated with an increased risk of breast cancer that increases with duration. This increase in risk is large enough, and well enough supported, to be considered along with the other risks and benefits of postmenopausal hormone therapy.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36341997000400014breast neoplasmsestrogensmenopausereview
spellingShingle HANKINSON SUSAN E
STAMPFER MEIR J
Estrogens and breast cancer
Salud Pública de México
breast neoplasms
estrogens
menopause
review
title Estrogens and breast cancer
title_full Estrogens and breast cancer
title_fullStr Estrogens and breast cancer
title_full_unstemmed Estrogens and breast cancer
title_short Estrogens and breast cancer
title_sort estrogens and breast cancer
topic breast neoplasms
estrogens
menopause
review
url http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36341997000400014
work_keys_str_mv AT hankinsonsusane estrogensandbreastcancer
AT stampfermeirj estrogensandbreastcancer